West Pharmaceutical Services, Inc.
WST
$263.51
-$15.59-5.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.77% | -30.98% | -4.34% | 22.19% | -3.47% |
| Total Depreciation and Amortization | 3.50% | -1.72% | 1.24% | 3.34% | 9.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,700.00% | 88.10% | -205.00% | 471.43% | -63.16% |
| Change in Net Operating Assets | -4,200.00% | -99.57% | 23,600.00% | -100.71% | 140.75% |
| Cash from Operations | 36.86% | -31.93% | 5.55% | 9.15% | 39.59% |
| Capital Expenditure | -5.47% | 32.03% | -29.03% | 18.86% | -10.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 112.50% | 20.00% | -- |
| Cash from Investing | -5.47% | 31.97% | -27.65% | 18.87% | -11.70% |
| Total Debt Issued | -- | -- | -100.00% | 270.57% | -- |
| Total Debt Repaid | -50.00% | -100.00% | 99.92% | -128.47% | -8,228.57% |
| Issuance of Common Stock | 18.18% | 41.94% | -48.33% | -11.76% | -59.52% |
| Repurchase of Common Stock | 99.63% | -149.08% | -4.20% | 72.01% | 31.28% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.66% | 0.65% | -5.52% | 0.68% | 0.68% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.86% | -113.35% | -6.99% | 70.50% | 19.45% |
| Foreign Exchange rate Adjustments | 117.65% | 137.44% | -304.50% | 1,109.09% | 87.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 231.22% | -1,176.19% | -114.09% | 128.73% | 38.28% |